Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients

Background: The systemic immune-inflammation index (SII) and Epstein-Barr virus DNA (EBV DNA) levels has been used as a prognostic marker for nasopharyngeal carcinoma (NPC) patients, but there is no in-depth study in locally advanced NPC patients and no research on the predictive value of their comb...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Ying, Shi, Liang-Liang, Zhu, Li-Sheng, Ding, Qian, Ba, Li, Peng, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974890/
https://www.ncbi.nlm.nih.gov/pubmed/33758605
http://dx.doi.org/10.7150/jca.52539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974890/
https://www.ncbi.nlm.nih.gov/pubmed/33758605
http://dx.doi.org/10.7150/jca.52539

Ejemplares similares